Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2022 / Reduce Your Biomarker Optimization Time Burden with the LabSat® Research

Reduce Your Biomarker Optimization Time Burden with the LabSat® Research

01/31/2022

Share

 

Biomarker discovery research in the field of immuno-oncology relies heavily on immunohistochemistry (IHC) assays, involving the execution of tailored protocols with a high number of steps, all of which are subject to optimization. This can be a lengthy process that can take days, weeks and even months to perform, and  requires  a  step-by-step  approach  to  finetune  protocol conditions such as assay temperature, antibody concentration or incubation times, in order to achieve optimal results with minimal investment of resources. Turnaround times of manual assays, even for single marker stainings, often require overnight incubations, and  existing  automated  staining  platforms,  while  faster,  still require several hours to stain one marker and can appear to be very expensive when performed for high throughput, which turns these optimization phases into a long burdensome processes.

 

 

The  LabSat®  Research  platform  is  an  automated  tissue immunostainer device. The system is pressurized and provides precise  temperature  and  reagent  flow  control  in  order  to finetune  and  optimize  conditions,  allowing  high-quality  and fast  multiplexing  of  up  to  6  markers  within  a  few  hours,  and can perform single-plex staining under 30 minutes. This short timeframe is particularly well suited to run fast protocols during assay optimization in just a few samples, instead of staining large batches of slides to save precious samples or reagents.

 

 

Lunaphore’s core technology, the Fast Fluidic Exchange (FFeX), utilizes  a  microfluidic  “Staining  Chip”  that  delivers  reagents sequentially  onto  a  tissue  sample.  The  chip  is  essentially  a microfluidic  tissue  processor  which  forms  a  shallow  chamber over the tissue sample. Reagents flow in and out of the chamber thanks  to  pressure  differentials  and  the  shallowness  of  the chamber increases the speed of exchange between antibodies and tissue epitopes, dramatically reducing the incubation times. Moreover, the staining chamber is filled almost instantaneously, preventing different areas of the tissue from being incubated unevenly, hence providing a great degree of signal uniformity in a controlled environment allowing more robust and reliable results. This active flow of reagents produces a fast exchange at the tissue surface, reducing the required incubation times.

 

 

>> Download Application Note as a PDF ​​​​​​​

 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

HIVE scRNAseq Solution: A Case Study Demonstrating Sample Stability & Fragile Cell Recovery

January 4, 2022

Rapid Immunohistochemistry, Multiplex IF and Digital Pathology Workflow

January 4, 2022

Reduce Your Biomarker Optimization Time Burden with the LabSat® Research

January 31, 2022

Label-free quantification of RNA methylations using targeted mass spectrometry

April 5, 2022

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.